Photo by David Trinks via Unsplash GLP-1 medications have drawn growing attention as treatments for obesity and diabetes, amid developments in pricing, availability and access.
Popular weight loss drugs including Ozempic and Wegovy will carry a new warning about a possible rare side effect that can sometimes lead…
Subscribe to The Business Journal to continue reading.
Already a subscriber? Log in to read the full story.
New PPIC study shows sharp divides in Central Valley politics, cost-of-living concerns
Posted: October 30, 2026 at 10:58 am
California is often seen through a coastal-inland lens, but public
Read more »
Prop. 43 asks who should clear the two-thirds bar on local taxes
Posted: October 27, 2026 at 9:24 am
Does it matter who writes a tax? Under Proposition 13,
Read more »A subscription opens up all of The Business Journal’s premium reporting, exclusive lists and special editions — everything we produce for the people who do business in the Central Valley.
Join the Valley business leaders who read us first.
Already a subscriber? Sign in
